TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
LinkoCare Life Sciences AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
25
|
141
|
0 |
| Financial expenses |
2
|
4
|
1 |
| Earnings before taxes |
-381
|
-148
|
-315 |
| EBITDA |
-373
|
-131
|
-293 |
| Total assets |
146
|
205
|
77 |
| Current assets |
141
|
194
|
51 |
| Current liabilities |
64
|
34
|
37 |
| Equity capital |
82
|
170
|
40 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
4
|
4
|
4 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
56.2%
|
82.9%
|
51.9% |
| Turnover per employee |
6
|
35
|
0 |
| Profit as a percentage of turnover |
-1524.0%
|
-105.0% | |
| Return on assets (ROA) |
-259.6%
|
-70.2%
|
-407.8% |
| Current ratio |
220.3%
|
570.6%
|
137.8% |
| Return on equity (ROE) |
-464.6%
|
-87.1%
|
-787.5% |
| Change turnover |
-116
|
141
|
-1 |
| Change turnover % | -82% | -100% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.